B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MC3R

MOLECULAR TARGET

melanocortin 3 receptor

UniProt: P41968NCBI Gene: 415910 compounds

MC3R (melanocortin 3 receptor) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MC3R

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alpha-MSH3.4731
2bremelanotide [Supplementary Concept]2.087
3Fluoxetine0.691
4melanotan-II [Supplementary Concept] synthetic cyclic heptapeptide,0.691
5Sertraline0.691
6Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
7Chlorhexidine0.691
8Fenoterol0.691
9Fluspirilene0.691
10Nebivolol0.691

About MC3R as a Drug Target

MC3R (melanocortin 3 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented MC3R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MC3R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.